2017
DOI: 10.18632/oncotarget.19094
|View full text |Cite
|
Sign up to set email alerts
|

Decreased risk of dementia in migraine patients with traditional Chinese medicine use: a population-based cohort study

Abstract: Patients with migraine are reportedly at increased risk of developing dementia. We aimed to investigate the association between traditional Chinese medicine (TCM) use and dementia risk in migraine patients. This longitudinal cohort study used the Taiwanese National Health Insurance Research Database to identify 32,386 diagnosed migraine patients aged 20 years and above who received treatment from 1997 to 2010. To balance comparability between TCM users and non-TCM users, we randomly selected equal numbers from… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 45 publications
1
13
0
Order By: Relevance
“…[7] Notably, pretreatment with traditional Chinese medicine that exerts neuroprotective and antioxidant effects in patients with migraine significantly decreased the risk of dementia in patients aged 70 to 79 years, suggesting a causal relationship between migraine and dementia. [18]…”
Section: Discussionmentioning
confidence: 99%
“…[7] Notably, pretreatment with traditional Chinese medicine that exerts neuroprotective and antioxidant effects in patients with migraine significantly decreased the risk of dementia in patients aged 70 to 79 years, suggesting a causal relationship between migraine and dementia. [18]…”
Section: Discussionmentioning
confidence: 99%
“…Trikatu [ 51 ], a spice concoction made with black pepper, long pepper, and dried ginger has been advised to be of value against rheumatoid arthritis by Ayurveda, a classical traditional medicinal system from India. In Chinese traditional medicine, Xiaoyao-san , a combination of various spices, has been recommended for management of stress and depression-related disorders [ 52 ].…”
Section: Discussionmentioning
confidence: 99%
“…Strong REG signal for anti-migraine medicines was not accompanied by any tests for such in controlled trials. Instead in (Vuralli et al, 2018 in Table 2, [38], [39]), a mechanistic link between migraine and cognitive decline is discussed as under-appreciated. This leads to idea that anti-migraine medications may contribute to preventing gradual long-term cognitive decline as well, thus producing a validated database signal.…”
Section: Screening Of Individual Pharmacological Mechanisms For Corrementioning
confidence: 99%
“…On the other side, analgesics (0.45, 46 df), corticosteroids (0.34, 42 df), anti-acid (0.45, 16 df), anti-arrythmic (0.55, 13 df), antibiotics (0.5, 5 df), anti-cancer therapies (0.25, 29 df), statins (0.6, 13 df), antidepressants (0.45, 17 df), antifungals (0.4, 19 df), overall antihypertensives (0.9, 28 df), bronchodilators (0.6, 17 df) display the opposite trend of distributing in favour of the lower Z-score octiles. Thus, PDE5 inhibitors [42], antiplatelet [43,44], vasodilators [43,45], antimigraine [38,39], antivirals [46], probiotics [47], magnesium [48,49], transdermal oestrogen ( Table 2) and possibly metformin [40,41,50,51] are the agents of interest to perhaps combine with the multivitamin-multimineral formulas of Table 2. Conversely, the signals by corticosteroids [52,53], anti-cancer therapies [54,55], anti-acid drugs [56,57], infections underlying use of antibiotics and antifungals [58], the link between dementia and respiratory deficiency [59], between dementia and cardiac arrythmia [44] mostly align with outside evidence of involvement in neurodegeneration.…”
Section: Screening Of Individual Pharmacological Mechanisms For Corrementioning
confidence: 99%